Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03936075
Other study ID # 62/19-06-18
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 1, 2018
Est. completion date December 31, 2020

Study information

Verified date July 2020
Source Aalborg University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is an RCT pilot study to explore the potential effects of the Guided Imagery & Music method for women with breast or gynecologic cancer, during active treatment. The study explores the potential impact in quality of life parameters such as mood, fatigue, and hope.


Description:

Guided Imagery and Music is a music-assisted psychotherapy method which has been used as a complementary, supportive psychosocial therapy in cancer care. However, its effects have never been explored during the period of active chemotherapy or radiotherapy treatment in various cancer populations, and especially gynecologic and breast cancer. This pilot study is an effort to explore the feasibility of the method to increase quality of life in this population by possibly reducing side-effects of treatment such as fatigue, improving mood, and building resilience as expressed through levels of hope.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 20
Est. completion date December 31, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Speaking Greek

- receiving chemotherapy or radiotherapy treatment for breast or gynecologic cancer

- first occurrence or metastatic

- have an interest in engaging in creative psychotherapies through music

Exclusion Criteria:

- women with active psychosis or PTSD symptomatology

- women receiving other psychological support

- women too ill to participate according to doctors' instructions

Study Design


Intervention

Behavioral:
the Guided Imagery and Music method
the method involves listening to the music while describing the experience to the therapist, any visual imagery that is evoked by the music, emotions, body sensations, thoughts or memories. after the music listening session, there is discussion upon making meaning of the experience and finding resources as potential coping skills
standard care and verbal counselling
the participants receive their usual cancer treatment and two individual counselling sessions

Locations

Country Name City State
Greece Aretaieion University Hospital Athens Attiki

Sponsors (3)

Lead Sponsor Collaborator
Aalborg University Aretaieion University Hospital, SONORA Organisation for Music Therapy and Research

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Profiles of Mood States (POMS) Brief version (adapted) Brief version adapted in Greek. A 30-item scale designed to assess six different moods namely tension, anger, vigor, fatigue, depression, confusion. It requires to indicate mood state over the last week, with a single word, each item ranging from 0(not at all) to 4 (extremely). The questionnaire is a sum of its 6 sub scales (each addressing the aforementioned moods), with a total score from 0 to 120. Lower scores indicate better mood states. Baseline and up to 12 weeks (post-intervention)
Secondary Herth Hope Index A 12-item Likert-format instrument assessing current levels of hope from 1(strongly disagree) to 4 (strongly agree). It consists of three sub scales, examining interconnectedness, temporality and spirituality, and positiveness or expectancy. A higher score of the sum or the 3 sub scales indicates a higher hope level with scores ranging from 12 to 48. Baseline and up to 12 weeks (post-intervention)
Secondary Cancer-related Fatigue Scale (CFS) An instrument consisting of 15 items that assess physical, affective, and cognitive dimensions of fatigue at present moment, with Likert scales ranging from 1 to 5. the physical sub scale consists of 7 items, the affective sub scale consists of 4 items, and the cognitive sub scale consists of 3 items and the total of all 3 sub scales indicate that greater scores correspond to greater fatigue levels. Baseline and up to 12 weeks (post-intervention)
Secondary Visual Analogue Scale for Hope (VAS-H) VAS is a single, frequent measurement to address the current levels of hope. Its s based on a 100cm horizontal line from 1cm (hopeless) to 100cm (hopeful) obtained 6 times throughout the completion of intervention (up to 12 weeks)
Secondary Visual Analogue Scale for Fatigue (VAS-F) VAS is a single, frequent measurement to address the current levels of fatigue. Obtained 6 times throughout the completion of intervention (up to 12 weeks)
See also
  Status Clinical Trial Phase
Recruiting NCT04416087 - Exercise and Tumor Blood Flow in Breast Cancer Patients N/A
Active, not recruiting NCT04726319 - Family History App in Personalized Medicine N/A
Recruiting NCT05800834 - Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds Phase 2
Completed NCT04692168 - Influence of Chemotherapy on Postural Control in Women With Cancer
Recruiting NCT06152419 - Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project N/A
Recruiting NCT03709134 - Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy
Completed NCT03282214 - A Self-Management Energy Conservation Program for Cancer-Related Fatigue Phase 2
Recruiting NCT06275321 - Physical Exercise Benefits for Cancer Patients N/A
Recruiting NCT05711030 - Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery N/A
Suspended NCT03271853 - Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis. N/A
Active, not recruiting NCT03144947 - Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients Phase 2
Completed NCT02996201 - Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial N/A
Active, not recruiting NCT03282097 - Decisions About Cancer Screening in Alzheimer's Disease N/A
Recruiting NCT05573022 - Impact of a Patient Decision Aid Intervention N/A
Completed NCT05161312 - A Guided Online Intervention to Improve Quality of Life in Breast Cancer Patients - a Randomised Clinical Trial N/A
Completed NCT04836221 - Comorbidities And Reducing inEquitieS N/A
Recruiting NCT06391749 - Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
Not yet recruiting NCT06345534 - FAST-FORWARD vs HAI5 N/A
Enrolling by invitation NCT06409221 - VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study
Not yet recruiting NCT03910283 - Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer N/A